Master's Program Overview
The breadth of Penn's Master of Biotechnology Program and its cross-disciplinary
approach prepare students with the knowledge and skills they need for
leadership in the biotechnology and pharmaceutical industries. According
to their interests, background and career goals, students can choose from
one of four parallel tracks or a dual-degree MBA/MB
Management Track:
- Molecular Biotechnology,
which emphasizes molecular biology
- Biopharmaceutical/Engineering Biotechnology,
which stresses drug discovery and biopharmaceutical manufacturing
- Computational Biology/Bioinformatics,
which prepares students for analysis of ever-expanding genomic and proteomic
databases
- Biomedical Technologies,
which focuses on clinical issues such as biomaterial, tissue engineering,
and imaging.
Providing standards and flexibility, each track has both required courses
and electives. Core courses common to all tracks insure each student's
exposure to all areas of biotechnology. All students learn about topics
ranging from the latest developments in recombinant DNA technology to
non-technical issues that students must understand to bring biotechnology
products to market such as bioethics, government regulatory and drug-approval
policies and patent law.
Students can enroll in either the fall or spring term. Full-time
students can complete the program's required 11 course units in 3 terms.
|
